The technology will help embryologists assess embryo quality metrics
By Leslie Kenny, Oxford Healthspan founder
by Olivia Brooks, investor at Founders Factory
The study found that two thirds of people in the UK expect their employer to cover IVF
As many as 40 per cent of women in the US are affected by overactive bladder
The company aims to advance novel oncology discovery programme
Employer fertility benefits have seen a dramatic rise in the US, but Europeans have not jumped on the trend
The treatment was able to reduce the risk of death by 31 per cent compared to chemotherapy during study
CorEvitas aims to fulfil global regulatory requirements for the safety of medications and vaccines during pregnancy
Nurofen's Gender Pain Gap Index Report raises awareness of gender bias in pain management
